1. Home
  2. NUWE vs ICCM Comparison

NUWE vs ICCM Comparison

Compare NUWE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuwellis Inc.

NUWE

Nuwellis Inc.

N/A

Current Price

$3.77

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.99

Market Cap

3.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NUWE
ICCM
Founded
1999
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.6M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
NUWE
ICCM
Price
$3.77
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $22.67
AVG Volume (30 Days)
★ 1.4M
133.6K
Earning Date
11-12-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $8,270,000.00
N/A
Revenue This Year
$19.32
$20.80
Revenue Next Year
$12.01
$115.66
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.28
$0.13
52 Week High
$222.30
$9.54

Technical Indicators

Market Signals
Indicator
NUWE
ICCM
Relative Strength Index (RSI) 40.20 51.77
Support Level $0.28 $0.96
Resistance Level $5.74 $2.50
Average True Range (ATR) 0.51 0.11
MACD 0.02 0.06
Stochastic Oscillator 0.86 72.92

Price Performance

Historical Comparison
NUWE
ICCM

About NUWE Nuwellis Inc.

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: